OrthoPediatrics KIDS Sports medicine/other — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about OrthoPediatrics's sports medicine/other — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is OrthoPediatrics's sports medicine/other — net revenue?
- OrthoPediatrics (KIDS) reported sports medicine/other — net revenue of $875K in Q1 2026.
- How has OrthoPediatrics's sports medicine/other — net revenue changed year-over-year?
- OrthoPediatrics's sports medicine/other — net revenue decreased by 0.6% year-over-year, from $880K to $875K.
- What is the long-term trend for OrthoPediatrics's sports medicine/other — net revenue?
- Over 4 years (2021 to 2025), OrthoPediatrics's sports medicine/other — net revenue has grown at a -1.1% compound annual growth rate (CAGR), from $4.17M to $4M.
- What does sports medicine/other — net revenue mean?
- This metric represents the total net revenue generated from the sale of products and services within the company's sports medicine and miscellaneous product categories. It reflects the market demand and commercial performance of specialized orthopedic solutions outside of the core pediatric implant business. Tracking this revenue stream helps investors assess the company's diversification strategy and the growth potential of its secondary product lines.